EUVIMEDEUVIMED entdecken
Kommentar

Wedging the door open on platelet‐type von Willebrand disease

Matthew Auton iD, Alexander Tischer

British Journal of Haematology · 2023

DOI: 10.1111/bjh.19094 ↗

Kurz gefasst

Kommentar in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Matthew Auton und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: von Willebrand Diseases. Die Arbeit nennt 10 Literaturangaben. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In their paper, the authors identify another mutation located within the leucine-rich repeat (LRR) domain of GPIbα that causes platelet-type von Willebrand disease (PT-VWD). The amino acid substitution, p.Leu194Phe (L194F) caused by a heterozygous c.580C→T mutation, is the second gain-of-function mutation discovered that lies outside the flexible C-terminal disulphide loop within the LRR scaffold of GPIbα. Prior to 2022, all known PT-VWD mutations occurred in the C-terminal disulphide loop until Bury et al. identified the first PT-VWD variant, p.Arg127Gln (R127Q), within LRR5.1 Lying on the outside dorsum surface of GPIbα, distal to the loop, R127Q was the first variant of PT-VWD to confirm allostery within GPIbα.1 Hydrogen–deuterium exchange mass spectrometry previously demonstrated that the classic PT-VWD variants within the loop locally enhance the dynamics of the loop, favouring an open conformation, while subtly enhancing local fluctuations in the LRR5 and LRR6 repeats.2 Similar to these variants, but located on the opposite side of the GPIbα structure (Figure 1), R127Q reciprocally enhances the conformational dynamics of the loop.1 By contrast, the newly discovered L194F variant, by Monteiro et al. in this issue, occurs on the inside palm surface of GPIbα, within LRR7, proximal to the loop.3 It introduces a phenylalanine with a large aromatic side chain that they hypothesize sterically interferes with other aromatic residues F217 in LRR8 and perhaps W246 in the flexible loop (Figure 1) forcing an open conformation that favours a higher affinity state of GPIbα. It is known that the classic PT-VWD variants within the loop predominantly act locally through sequence while indirectly affecting the conformational dynamics of distal LRRs.2 R127Q acts indirectly and distally through allosteric modulation of GPIbα conformational states.4 L194F probably acts directly and proximally through space by inhibiting a closed conformation that poises GPIbα in a thermodynamically favoured binding competent state. Although the more recent work on the dynamics of GPIbα support Monteiro et al.'s proposal,1, 2 their hypothesis should be specifically verified through experiments on recombinant GPIbα harbouring L194F. R127Q and L194F represent a new class of gain-of-function variants located in the LRR distinct from the classical variants located in the disulphide loop of GPIbα. Other missense variants in the LRR cause variant Bernard–Soulier disease (BSD), a loss-of-function phenotype with decreased or absent GPIbα-VWF binding affinity. A select few of these (L73F, C81R and L145P)*5-8 likely alter side chain stacking inside the LRR scaffold and affect the folding of GPIbα (Figure 1). However, the side chain of L194 in LRR7 is juxtaposed with A172 in LRR6, the location known for the A172V Bolzano mutation that causes variant BSD (Figure 1).9 PT-VWD is extremely rare, with approximately 60 patients identified worldwide. The present case, presented by Monteiro et al., illustrates how challenging the diagnosis of PT-VWD is becoming. The gain-of-function constitutes a pseudo-type 2B VWD that is only distinguishable from VWD through gene sequencing of both VWF and GPIbα and the enhanced binding affinity must then be confirmed with recombinant proteins. Similar to R127Q, only ristocetin-induced agglutination of patient platelets indicated a gain-of-function for the L194F variant of GPIbα. Both the Monteiro et al. and Bury et al. studies also showed moderately increased mean platelet volumes, a characteristic common to the variant BSD.10 Platelets from the patient with L194F were ~14 fL versus 12 fL from the patient with R127Q. With 12 being the top end of the normal range, both are still less than reported from those with the Bolzano A172V variant, ~15 fL.10 In addition, Monteiro et al.'s patient also showed lower than normal expression of GPIbα on platelet surfaces indicating that the mild clinical phenotype observed may, in some cases, result from a compensation between the increased intrinsic binding affinity of GPIbα for VWF balanced by overall GPIbα expression levels on platelets. While L194F presents clinically as gain-of-function as in PT-VWD, it shares some properties in common with variant BSD. Monteiro et al.'s observation in the clinic is unique and it is expected that more PT-VWD variants will continue to be discovered throughout the GPIbα N-terminal domain. Like L194F, future variants may also be classified as unknown significance. Presuming that the open:closed conformational equilibrium is the driving mechanism regulating affinity, it is interesting to hypothesize that amino acid substitutions might also induce loss-of-function through stabilizing the closed conformation of GPIbα. Although no such mutation has yet been discovered, the present discovery in this issue implies the possibility that favourable contacts between the loop residues and the palm of the LRR scaffold could cause a pseudo-type 2M VWD phenotype. The Bolzano variant BSD could provide clues to such a hypothetical interaction. These recent discoveries of both proximal and distal interactions between the loop and the LRR scaffold of GPIbα by Monteiro et al. and Bury et al. expand the known spectrum of GPIbα dysfunction yielding new insights into the conformational regulation of primary haemostasis. Matthew Auton and Alexander Tischer wrote the manuscript and prepared the figure. Invited Commentary from the British Journal of Haematology. No conflicts of interest to disclose. For original data, please contact [email protected].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand DiseasesHumansBlood Plateletsvon Willebrand FactorPlatelet Glycoprotein GPIb-IX ComplexMutation

Stichwörter der Autor:innen

GPIbαPT-VWDallosteric and steric activationbernard soulier diseaseleucine rich repeatmutation

Substanzen

von Willebrand FactorPlatelet Glycoprotein GPIb-IX Complex

Autor:innen und Institutionen

  • Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Matthew Auton

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Auton, M., & Tischer, A. (2023). Wedging the door open on platelet‐type von Willebrand disease. British Journal of Haematology. https://doi.org/10.1111/bjh.19094

Vancouver

Auton M, Tischer A. Wedging the door open on platelet‐type von Willebrand disease. British Journal of Haematology. 2023. doi:10.1111/bjh.19094

BibTeX
@article{Auton2023,
  author = {Auton, Matthew and Tischer, Alexander},
  title = {Wedging the door open on platelet‐type von Willebrand disease},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.19094}
}
Kostenlos starten →